This test is most useful if any of these apply to you.
If you have heard the phrase "leaky gut," this is the blood marker most often sold as a way to measure it. The honest starting point is that the science is unsettled, and knowing that upfront changes how you should read your result.
This is a research-stage test, not an established clinical one. It can offer an early, exploratory window into your gut barrier and inflammation, but a single number should never be treated as a diagnosis on its own.
Zonulin (a protein also known as pre-haptoglobin 2) acts like a signal that temporarily unlocks the seals between the cells lining your intestine. When those seals loosen, larger molecules can slip from the gut into the bloodstream, which the immune system may read as a threat. In theory, a higher blood level reflects a gut wall that is opening up more than it should.
In practice, the picture is messier. Higher blood levels show up alongside obesity, high blood pressure, infection, and several immune conditions, so the marker is better understood as a general signal that something is stressing the body than as a precise readout of the gut alone.
This is the single most important thing to understand before ordering. A widely used commercial lab test (an ELISA, a common antibody-based blood assay) does not reliably detect pre-haptoglobin 2 itself. When researchers checked it directly, the test did not track the expected genetics, failed to recognize lab-made pre-haptoglobin 2, and most likely picked up other related proteins instead. One study pointed to a protein called properdin as the leading candidate, while other work found complement C3 and haptoglobin among the proteins actually detected, with the specific look-alike depending on which commercial kit was used.
This matters because a reported "high zonulin" may not mean high zonulin specifically. It may reflect a family of look-alike proteins the assay cannot fully separate. Any result you get should be read with that limitation in mind, and results from different labs may not be comparable.
The most consistent human signal is metabolic, not gastrointestinal. In a study of 363 adults, higher serum zonulin tracked with larger waist circumference, higher diastolic blood pressure, and higher glucose, and with roughly higher odds of overweight, obesity, and high blood fats. In the same cohort, gut symptoms and gut diseases had no clear influence on levels, which cuts against the popular idea that this is mainly a digestive marker.
In children and adolescents with obesity, fasting levels were positively linked to insulin resistance, and levels rose after a glucose drink during testing. This meal-related rise is one reason a single non-fasting sample can mislead.
In people with high blood pressure, zonulin was markedly elevated and closely mirrored systolic pressure, the top number that reflects the force in your arteries. In chronic heart failure, higher levels tracked with worse heart remodeling and poorer physical performance such as balance and grip strength. In people having a major heart attack, levels were higher than in those with stable chest pain and moved together with a marker of gut-derived bacterial toxin in the blood.
Blood levels climb during serious acute illness. Patients with sepsis had higher plasma zonulin (a middle value of 6.61 ng/mL) than both post-surgical patients (3.40 ng/mL) and healthy people (3.55 ng/mL). Among hospitalized COVID-19 patients, those with higher baseline levels were more likely to die even after accounting for age, sex, and obesity, and levels moved with kidney and clotting markers.
There is a real gut signal in narrow situations. In celiac disease, mean serum zonulin was more than double that of controls (8.5 vs 3.7 ng/mL). For telling apart non-celiac gluten sensitivity from diarrhea-type irritable bowel syndrome, zonulin alone reached about 81% accuracy, and a simple model adding symptoms and sex reached 89%.
But the evidence is not uniform. A separate study of 344 people concluded that serum zonulin failed to identify irritable bowel syndrome, functional dyspepsia, or non-celiac wheat sensitivity. So even within gut medicine, this remains a contested marker best used for specific questions, not general screening.
Higher blood levels have been reported across a wide range of immune-related states, including severe asthma, allergic disease in children, bipolar disorder, and multiple sclerosis with imaging-confirmed disruption of the barrier around the brain. This breadth is exactly why the marker is not disease-specific: elevation points to systemic stress on barriers and inflammation, not to any one condition.
The link to the brain barrier is not settled, though. In a separate study of 217 people, blood zonulin varied widely depending on the assay used and did not line up with directly measured blood-brain barrier permeability, so the two appear to be dissociated. That is another reason to read any single elevated result cautiously rather than as proof that a specific barrier is failing.
| Who Was Studied | What Was Compared | What They Found |
|---|---|---|
| Adults with asthma | Severe versus mild versus healthy | Roughly three times higher in severe asthma (about 52 versus 17 ng/mL) |
| Hospitalized COVID-19 patients | Those who died versus survivors | Higher baseline levels linked to death, even after adjusting for age, sex, and obesity |
| People with high blood pressure | Zonulin versus arterial pressure | Strong link with higher systolic blood pressure |
Sources: Kim NY et al. 2023 (severe asthma); Palomino-Kobayashi et al. 2022 (COVID-19); Kim S et al. 2018 (high blood pressure).
What this means for you: a single elevated reading does not tell you which system is under strain. It is a prompt to look at the bigger picture, not a verdict about your gut, heart, or immune system by itself.
Some findings run against the obvious "higher equals worse" reading, and they are worth resolving so you are not left confused. In one study of advanced diabetic kidney disease, blood levels were actually lower than in diabetics without kidney disease, and levels rose alongside better kidney filtration. Yet the kidney picture is contested: a more recent study found the opposite, with higher zonulin across chronic kidney disease stages 3 to 5 and levels falling as filtration worsened. In pregnancy with severe vomiting, levels fell as the condition got worse. In HIV, gut tissue lost zonulin while blood levels rose, suggesting the protein shifted from the gut into the blood.
The framework that reconciles this: blood zonulin is not a clean "good number, bad number" marker. It reflects a moving balance between where the protein is made, where it redistributes, and how well the kidneys clear it. That is why it must always be interpreted in context rather than as a fixed scale.
A single blood draw is not a reliable snapshot. In a timed study, most people with measurable baseline levels showed large swings across draws at 0, 6, 24, and 30 hours. The authors concluded plainly that one measurement is not recommended for assessing the gut barrier. Antibodies against zonulin measured in the same people were far more stable, though that is a separate test from this one.
For a research marker like this, that instability is exactly why a trend beats a snapshot. No professional society has issued formal guidance on how often to test, so the following reflects expert judgment rather than guidelines: get a baseline, and if you are making real changes such as weight loss or a dietary overhaul, retest in 3 to 6 months, always fasting and away from acute illness. Because assays differ, keep your retests at the same lab so the numbers can be compared.
If your level comes back high, treat it as a flag to widen the workup rather than a diagnosis. The useful next step is to look at what it might be riding along with: inflammation (such as hs-CRP, a sensitive marker of body-wide inflammation), glucose and HbA1c, and body composition. If you have digestive symptoms or family history of celiac disease, celiac blood testing is a more established path than acting on zonulin alone.
A pattern of high zonulin together with rising inflammation, worsening glucose, or unexplained gut symptoms is a stronger reason to involve a clinician than any single value. A gastroenterologist is the right specialist if gut disease is the concern, while a high reading during or shortly after an infection is more likely temporary than meaningful. When in doubt, repeat the test at the same lab before drawing conclusions.
Evidence-backed interventions that affect your Zonulin level
Zonulin is best interpreted alongside these tests.
Zonulin is included in these pre-built panels.